Core Viewpoint - GIC Private Limited has reduced its stake in Longyuan Power (00916) by selling 7.928 million shares at a price of HKD 8.3166 per share, totaling approximately HKD 65.934 million, resulting in a new holding of about 228 million shares, representing 6.87% of the company [1] Summary by Category - **Share Reduction**: GIC Private Limited sold 7.928 million shares of Longyuan Power [1] - **Transaction Details**: The shares were sold at a price of HKD 8.3166 each, amounting to a total of approximately HKD 65.934 million [1] - **Current Holdings**: After the sale, GIC's remaining shares in Longyuan Power are approximately 228 million, with a holding percentage of 6.87% [1]

Core Viewpoint - GIC Private Limited has increased its stake in Heng Rui Medicine (01276) by acquiring 486,200 shares at a price of HKD 82.7931 per share, totaling approximately HKD 40.254 million, resulting in a new holding of 52,018,600 shares, which represents 20.15% of the company [1] Summary by Category - **Share Acquisition** - GIC Private Limited purchased 486,200 shares of Heng Rui Medicine [1] - The acquisition price was HKD 82.7931 per share [1] - The total investment amounted to approximately HKD 40.254 million [1] - **Ownership Structure** - Following the acquisition, GIC's total shareholding in Heng Rui Medicine reached 52,018,600 shares [1] - GIC's ownership percentage in the company is now 20.15% [1]

香港联交所最新资料显示，10月13日，GIC Private Limited增持基石药业(02616)226.1万股，每股作价 6.9576港元，总金额约为1573.11万港元。增持后最新持股数目为8861.8万股，持股比例为6%。 ...

智通财经APP获悉，香港联交所最新资料显示，10月13日，GIC Private Limited增持基石药业 (02616)226.1万股，每股作价6.9576港元，总金额约为1573.11万港元。增持后最新持股数目为8861.8万 股，持股比例为6%。 ...

Group 1 - GIC Private Limited increased its stake in Haitian Flavor Industry Co., Ltd. by purchasing 225,000 shares at an average price of HKD 34.9621 per share, totaling approximately HKD 7.8665 million [1] - Following this transaction, GIC's total shareholding in Haitian Flavor rose to 32,225,800 shares, increasing its ownership percentage from 10.99% to 11.07% [1][2]

Core Insights - Klarna has successfully gone public on the New York Stock Exchange, with its stock price increasing by 30% on debut, reaching $52 per share, which gives the company a valuation of $15.1 billion and raised $1.37 billion from the IPO [1][4][5] - The IPO marks a significant milestone for Klarna, which was founded in 2005 and had been hinting at going public since 2019, facing delays due to market conditions [2][4] - Klarna's valuation has seen a dramatic decline from its peak of $45.6 billion in 2021 to $6.7 billion in 2022, reflecting the challenges faced by the fintech sector [4][5] Company Overview - Klarna is a Swedish "buy now, pay later" company that has evolved significantly since its founding, with a strong consumer base and market position [5] - The company has made operational changes, including requiring remote employees to return to the office and shifting focus back to customer support roles [6] IPO Details - Klarna's IPO is the first major public offering of the fall season, with expectations of more companies following suit before year-end [3] - The IPO price of $40 per share was a significant markdown from previous valuations, indicating a shift in investor sentiment [4][5] Investor Insights - Sequoia Capital emerged as the largest beneficiary of Klarna's IPO, holding a stake worth approximately $3.5 billion after the listing [9][16] - Other notable shareholders include cofounder Victor Jacobsson, whose stake is valued at $1.38 billion, and CEO Sebastian Siemiatkowski, with a stake worth about $1.17 billion [17][29] - Heartland A/S, owned by billionaire Anders Holch Povlsen, holds a stake valued at $1.36 billion, while Commonwealth Bank of Australia has a stake worth $798 million [21][30] Market Context - Klarna's IPO comes amid a challenging environment for fintech companies, with rising interest rates and regulatory risks impacting investor confidence [5] - The company has faced significant losses, prompting it to set aside more capital to cover potential defaults from customers [5]

香港联交所最新资料显示，9月8日，GIC Private Limited减持紫金矿业（601899）(02899)284万股，每股 均价27.8819港元，总金额约为7918.46万港元。减持后最新持股数目约为2.98亿股，最新持股比例为 4.98%。 ...

智通财经APP获悉，香港联交所最新资料显示，9月8日，GIC Private Limited减持紫金矿业(02899)284万 股，每股均价27.8819港元，总金额约为7918.46万港元。减持后最新持股数目约为2.98亿股，最新持股 比例为4.98%。 ...

Group 1 - GIC Private Limited increased its stake in 和铂医药-B (02142.HK) by purchasing 40.22 million shares at an average price of HKD 12.7133 per share, totaling approximately HKD 511 million [1] - Following the acquisition, GIC's total shareholding in 和铂医药-B rose to 53.977 million shares, increasing its ownership percentage from 1.62% to 6.37% [1]

香港联交所最新资料显示，8月29日，GIC Private Limited增持和铂医药(02142)4022.2万股，每股作价 12.7133港元，总金额约为5.11亿港元。增持后最新持股数目为5397.7万股，最新持股比例为6.37%。 ...